Business Wire

LatticeFlow AI Introduces Suite 2.0 to Enhance Performance, Reliability, and Compliance in AI Systems

Share

LatticeFlow AI, a leader in enabling organizations to build trustworthy AI systems, today introduced its Suite 2.0 to elevate performance, reliability, and compliance of AI systems.

As the next generation of AI systems must be built from the ground up to be trustworthy and compliant, LatticeFlow AI Suite 2.0 bridges critical gaps between machine learning operations, technical validation, and regulatory demands, empowering organizations to deploy AI systems that drive business value, and excel in safety, trustworthiness, and regulatory compliance.

The Last Mile of AI

While new tools and open-source resources have made AI development easier, few AI models successfully transition to production and consistently deliver business value. Emerging AI regulations and internal risks—such as model blind spots and safety concerns—add complexity, requiring AI models to be resilient and compliant before deployment.

To address these challenges, LatticeFlow AI presented the concept of The Last Mile of AI, a framework for the critical, final steps to ensure successful AI deployments. The Last Mile of AI encompasses five essential challenges: validate data, accelerate model performance, automate internal AI controls, achieve regulatory compliance, and monitor ongoing risks and performance. With its Suite 2.0, LatticeFlow AI guides organizations through this “last mile,” enabling them to deliver AI systems that are not only technically performant but also robust, safe, and compliant.

“We are at a pivotal time in AI, where safety, security, and compliance are no longer optional. LatticeFlow AI is leading this evolution by automating key AI quality and risk controls, empowering teams to confidently navigate the last mile of AI, and ensuring their AI applications are high-performing, trustworthy, and safe for society,” said Dr. Petar Tsankov, CEO and Co-Founder of LatticeFlow AI.

Automated AI Health Checks: Proactive AI Control and Model Validation

As a core feature of the Suite 2.0, LatticeFlow AI introduces Health Checks, a groundbreaking capability that enables organizations to establish and automate internal controls for AI model performance and data quality. Health Checks allow teams to standardize quality evaluations across their AI models tailored to each company’s needs. The suite contains a library of pre-defined checks that can be customized to the use cases at hand and offers the ability to create custom checks relevant for a company’s domain. Health Checks operate on both data and model levels.

Data Health Checks provide expert-level analysis at the sample and annotation level, accelerating data preparation and preventing costly model errors. Pre-defined checks flag duplicate images, leaked samples, or mislabeled items. Custom checks allow monitoring use case-specific scenarios such as “images should not be rotated” with every dataset update.

Model Health Checks not only run basic sanity checks but also proactively detect risks such as model underperformance for specific metadata, both for default categories like image brightness and for custom concepts such as “images with people wearing glasses.” The suite offers multiple ways to detect and monitor potential blind spots, ensuring standardized diagnostics for different model versions and reinforcing compliance with both internal and regulatory standards.

By automating these processes, Health Checks allows AI teams to work more efficiently, enabling smaller teams to achieve expert-level insights without time-intensive manual processes or extensive data exploration. Most importantly, Health Checks enables executives to have full visibility into the quality and performance of their AI applications.

Jumio, a leading provider of AI-driven identity verification and compliance solutions, has partnered with LatticeFlow AI to build on the power of automated Health Checks. “Ensuring that our AI models are both safe and reliable is critical to providing the highest level of protection for our customers,” said Alix Melchy, Jumio VP of AI. “By partnering with LatticeFlow AI, we’re taking a proactive approach to identifying potential risks and enhancing the security of our AI models. This partnership is not just about improving performance—it’s about staying ahead of industry regulations and ensuring compliance with emerging AI standards.”

About LatticeFlow AI

LatticeFlow AI enables organizations to build performant, trustworthy, and compliant AI applications. As a pioneer in AI validation, LatticeFlow AI has developed COMPL-AI—the industry’s first comprehensive EU AI Act mapping in partnership with ETH Zurich and INSAIT, helping AI teams align with regulatory standards.

With Swiss government funding, LatticeFlow AI is advancing AI Assessments, a platform bridging AI governance and technical validation to meet evolving compliance and risk management needs.

Globally recognized for its impact, LatticeFlow AI has received the US Army Global Award and been named to CB Insights’ AI100 list of the world’s most innovative AI companies. As AI enters a critical phase, LatticeFlow AI empowers companies to deploy AI solutions that are resilient, compliant, and high performing.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241126720784/en/

Contacts

Media Enquiries:

Gloria Fernandez, Marketing Director
media@latticeflow.ai
LatticeFlow AI

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Marelli Extends Relationship with Wipro for Continued Evolution of IT Infrastructure26.11.2024 12:51:00 CET | Press Release

Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading technology services and consulting company, has today announced the extension of its work with Marelli, a global leader in automotive solutions, for an additional four years. As part of this engagement, Wipro FullStride Cloud will migrate Marelli’s Milan Data Centre and all their local server rooms to the Cloud to centralize their operations and provide a more agile and stable ecosystem. This transition to a more flexible and advanced cloud environment will empower Marelli to respond quickly to market changes, enable continuous innovation across their business, and strengthen their competitive edge. Ultimately, the project will help reduce the time-to-market for Marelli's products and services, creating long-term value for all stakeholders, continuing to advance Marelli's journey towards modernization and growth. “We are excited to begin a new chapter in our strategic partnership with our trusted partner, Marelli. Our wide-r

Delta-Fly Pharma Inc.: Progress Update of the Phase III Clinical Trial of DFP-1432326.11.2024 12:00:00 CET | Press Release

We are excited to share our latest development status. Similar to its position in the United States, we are pleased to announce that Afatinib, which is being treated with DFP-14323 in our ongoing Phase III clinical trial, has been approved by the Japanese Lung Cancer Society in its “Lung Cancer Treatment Guidelines 2024” (issued on October 20, 2024) as a first-line treatment for EGFR mutation-positive (uncommon mutation) non-small cell lung cancer (NSCLC), with a stronger recommendation than Osimertinib. The development of DFP-14323 is being conducted in patients (stage III/IV) with epidermal growth factor receptor (EGFR) mutation-positive uncommon mutation NSCLC in a Phase III clinical trial (superiority study) comparing DFP-14323 in combination with Afatinib (20 mg/day) and Afatinib (40 mg/day) alone. The strongly recommended treatment with afatinib as first-line therapy must accelerate the enrollment of NSCLC patients through this trial. The study is being conducted at 30 core hospi

Netmore Group and Vantage Towers Partner to Expand Nationwide LoRaWAN ® Connectivity in Portugal26.11.2024 12:00:00 CET | Press Release

Netmore Group, a leading global LoRaWAN network operator, and Vantage Towers, a major provider of telecommunications tower infrastructure to the European market, today announced a strategic partnership to deliver national LoRaWAN connectivity across Portugal to support the digital transformation and sustainability initiatives of utilities, municipalities, and other organizations. Like many regions across the globe, addressing water scarcity is a leading initiative across Portugal and a leading use case for low power wide area network (LPWAN) sensing technology. Record droughts this year have forced significant water restrictions and strained the operations of water utilities throughout the country, particularly in the southernmost Algarve region, where reservoirs are only 20% full on average. Additionally, Portugal loses nearly a third of its water through leaks, theft or illicit use, according to ERSAR, the country’s national water supply and sanitation agency. To combat these challen

Blackstone Credit & Insurance Announces $1 Billion Infrastructure Loan Portfolio Purchase From Santander26.11.2024 11:30:00 CET | Press Release

Blackstone and Santander Corporate & Investment Banking today announced an agreement under which funds managed by Blackstone Credit & Insurance (“BXCI”) will acquire interests in a $1 billion portfolio of high-quality infrastructure loans from Santander. The portfolio comprises loans that finance assets located largely in Western Europe and the US across the digital infrastructure, utility scale renewable, energy efficiency and transportation sectors. Robert Horn, Global Head of Infrastructure & Asset Based Credit at BXCI, said: “This transaction is consistent with our approach to working with leading financial institutions on large-scale, long-term, efficient solutions that support their capital goals.” Marcel Patiño, Global Head of Private Debt Mobilization at Santander CIB, said: “We are delighted to partner with Blackstone on this strategic transaction as we look to streamline our balance sheet while supporting further growth by Santander as a leading advisor and arranger in the St

Sudden Hearing Loss Study Reaches Milestone: AudioCure Pharma Enrolls More Than Half of the Patients in AC102 Study26.11.2024 10:02:00 CET | Press Release

Berlin-based start-up AudioCure Pharma has enrolled more than 50% of the planned patients in its ongoing Phase 2 clinical trial. The aim of the study is to test the efficacy of the new compound AC102 for the treatment of sudden hearing loss. As sudden hearing loss is usually treated with non-specific corticoids that are not approved for this indication or for which there is no clear evidence of efficacy, there is an urgent need for new therapies. This enrollment milestone is an important step in the development of AC102 and in addressing the unmet medical need for sudden hearing loss. The safety and tolerability of AC102 has already been successfully tested in healthy volunteers. “Recruitment for the trial is challenging because the compound can only be effective in the first few days after the onset of the sudden hearing loss and we can therefore only enroll patients in the study during this short window. I am therefore very pleased with this recruitment success, which underscores the

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye